Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Boyd

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Seminars in Nuclear Medicine|August 2, 2011
Preclinical assessment of strategies for enhancement of metaiodobenzylguanidine therapy of neuroendocrine tumorsRob J Mairs, Marie Boyd
Nuclear Medicine and Biology|December 4, 2008
Optimizing MIBG therapy of neuroendocrine tumors: preclinical evidence of dose maximization and synergyRob J Mairs, Marie Boyd
Lab on a Chip|August 2, 2016
Transitioning from multi-phase to single-phase microfluidics for long-term culture and treatment of multicellular spheroidsKay S McMillan, Marie Boyd, Michele Zagnoni
Nuclear Medicine and Biology|October 26, 2005
Gene manipulation to enhance MIBG-targeted radionuclide therapyRobert J Mairs, Natasha E Fullerton, Emilio Cosimo, et al.
The Journal of Pharmacy and Pharmacology|July 23, 2008
Radiation quality-dependent bystander effects elicited by targeted radionuclidesMarie Boyd, Annette Sorensen, Anthony G McCluskey, et al.
Cancer Letters|June 7, 2005
[131I]MIBG and topotecan: a rationale for combination therapy for neuroblastomaAnthony G McCluskey, Marie Boyd, Mark N Gaze, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 21, 2007
A transfectant mosaic xenograft model for evaluation of targeted radiotherapy in combination with gene therapy in vivoRobert J Mairs, Susan C Ross, Anthony G McCluskey, et al.
Dose-Response : a Publication of International Hormesis Society|July 24, 2008
Targeted radiotherapy: microgray doses and the bystander effectRobert J Mairs, Natasha E Fullerton, Michael R Zalutsky, et al.
EJNMMI Research|November 14, 2013
Radiosensitization of noradrenaline transporter-expressing tumour cells by proteasome inhibitors and the role of reactive oxygen speciesColin Rae, Mathias Tesson, John W Babich, et al.
The American Journal of Tropical Medicine and Hygiene|March 16, 2007
Mosquito feeding patterns and natural infection of vertebrates with Ross River and Barmah Forest viruses in Brisbane, AustraliaBrian H Kay, Ann Marie Boyd, Peter A Ryan, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Seminars in Nuclear Medicine|August 2, 2011
Preclinical assessment of strategies for enhancement of metaiodobenzylguanidine therapy of neuroendocrine tumorsRob J Mairs, Marie Boyd
Nuclear Medicine and Biology|December 4, 2008
Optimizing MIBG therapy of neuroendocrine tumors: preclinical evidence of dose maximization and synergyRob J Mairs, Marie Boyd
Lab on a Chip|August 2, 2016
Transitioning from multi-phase to single-phase microfluidics for long-term culture and treatment of multicellular spheroidsKay S McMillan, Marie Boyd, Michele Zagnoni
Nuclear Medicine and Biology|October 26, 2005
Gene manipulation to enhance MIBG-targeted radionuclide therapyRobert J Mairs, Natasha E Fullerton, Emilio Cosimo, et al.
The Journal of Pharmacy and Pharmacology|July 23, 2008
Radiation quality-dependent bystander effects elicited by targeted radionuclidesMarie Boyd, Annette Sorensen, Anthony G McCluskey, et al.
Cancer Letters|June 7, 2005
[131I]MIBG and topotecan: a rationale for combination therapy for neuroblastomaAnthony G McCluskey, Marie Boyd, Mark N Gaze, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 21, 2007
A transfectant mosaic xenograft model for evaluation of targeted radiotherapy in combination with gene therapy in vivoRobert J Mairs, Susan C Ross, Anthony G McCluskey, et al.
Dose-Response : a Publication of International Hormesis Society|July 24, 2008
Targeted radiotherapy: microgray doses and the bystander effectRobert J Mairs, Natasha E Fullerton, Michael R Zalutsky, et al.
EJNMMI Research|November 14, 2013
Radiosensitization of noradrenaline transporter-expressing tumour cells by proteasome inhibitors and the role of reactive oxygen speciesColin Rae, Mathias Tesson, John W Babich, et al.
The American Journal of Tropical Medicine and Hygiene|March 16, 2007
Mosquito feeding patterns and natural infection of vertebrates with Ross River and Barmah Forest viruses in Brisbane, AustraliaBrian H Kay, Ann Marie Boyd, Peter A Ryan, et al.
Pageof 4